Biodiversity Literature Repository

Submit to community
Liberated Data
Published June 30, 2015 | Version v1
Journal article Restricted

Secondary metabolites from Ganoderma

Authors/Creators

Description

Baby, Sabulal, Johnson, Anil John, Govindan, Balaji (2015): Secondary metabolites from Ganoderma. Phytochemistry 114: 66-101, DOI: 10.1016/j.phytochem.2015.03.010, URL: http://dx.doi.org/10.1016/j.phytochem.2015.03.010

Files

Restricted

The record is publicly accessible, but files are restricted. <a href="https://zenodo.org/account/settings/login?next=https://zenodo.org/records/10487183">Log in</a> to check if you have access.

Linked records

Additional details

Identifiers

LSID
urn:lsid:plazi.org:pub:807CFFF6C1717216FFAD7A749C77C76D

Related works

Has part
Figure: 10.5281/zenodo.10558187 (DOI)
Figure: 10.5281/zenodo.10558189 (DOI)

References

  • Adams, M., Christen, M., Plitzko, I., Zimmermann, S., Brun, R., Kaiser, M., Hamburger, M., 2010. Antiplasmodial lanostanes from the Ganoderma lucidum mushroom. J. Nat. Prod. 73, 897-900.
  • Akihisa, T., Tagata, M., Ukiya, M., Tokuda, H., Suzuki, T., Kimura, Y., 2005. Oxygenated lanostane-type triterpenoids from the fungus Ganoderma lucidum. J. Nat. Prod. 68, 559-563.
  • Arisawa, M., Fujita, A., Saga, M., Fukumura, H., Hayashi, T., Shimizu, M., Morita, N., 1986. Three new lanostanoids from Ganoderma lucidum. J. Nat. Prod. 49, 621- 625.
  • Boh, B., Hodzar, D., Dolnicar, D., Berovic, M., Pohleven, F., 2000. Isolation and quantification of triterpenoid acids from Ganoderma applanatum of Istrian origin. Food Technol. Biotechnol. 38, 11-18.
  • Boh, B., Berovic, M., Zhang, J., Zhi-Bin, L., 2007. Ganoderma lucidum and its pharmaceutically active compounds. Biotechnol. Annu. Rev. 13, 265-301.
  • Camargo, M.R., Kaneno, R., 2011. Antitumor properties of Ganoderma lucidum polysaccharides and terpenoids. Annu. Rev. Biomed. Sci. 13, 1-8.
  • Cao, Y., Wu, S.H., Dai, Y.C., 2012. Species clarification of the prize medicinal Ganoderma mushroom ''Lingzhi''. Fungal Divers. 56, 49-62.
  • Chairul, Tokuyama, T., Nishizawa, M., Shiro, M., Tokuda, H., Hayashi, Y., 1990. Malonate half-esters of homolanostanoid from an Asian Ganoderma fungus. Phytochemistry 29, 923-928.
  • Chairul, Tokuyama, T., Hayashi, Y., Nishizawa, M., Tokuda, H., Chairul, S.M., Hayashi, Y., 1991. Applanoxidic acids A, B, C and D, biologically active tetracyclic triterpenes from Ganoderma applanatum. Phytochemistry 30, 4105-4109.
  • Chairul, Chairul, S.M., Hayashi, Y., 1994. Lanostanoid triterpenes from Ganoderma applanatum. Phytochemistry 35, 1305-1308.
  • Chen, R.Y., Yu, D.Q., 1991. Application of 2d NMR techniques in the structure determination of ganosporelactone A and B. Yao Xue Xue Bao 26, 430-436.
  • Chen, R.Y., Yu, D.Q., 1993. Studies on the triterpenoid constituents of the spores from Ganoderma lucidum Karst. J. Chin. Pharm. Sci. 2, 91-96.
  • Chen, D.H., Shiou, W.Y., Wang, K.C., Huang, S.Y., Shie, Y.T., Tsai, C.M., Shie, J.F., Chen, K.D., 1999. Chemotaxonomy of triterpenoid pattern of HPLC of Ganoderma lucidum and Ganoderma tsugae. J. Chin. Chem. Soc. 46, 47-51.
  • Chen, X., Hu, Z.P., Yang, X.X., Huang, M., Gao, Y., Tang, W., Chan, S.Y., Dai, X., Ye, J., Ho, P.C., Duan, W., Yang, H.Y., Zhu, Y.Z., Zhou, S.F., 2006. Monitoring of immune response to a herbal immune-modulator in patients with advanced colorectal cancer. Int. J. Immunopharmacol. 6, 499-508.
  • Chen, M., Zhang, M., Sun, S., Xia, B., Zhang, H.Q., 2009a. A new triterpene from the fruiting bodies of Ganoderma lucidum. Yao Xue Xue Bao 44, 768-770.
  • Chen, Y.K., Kuo, Y.H., Chiang, B.H., Lo, J.M., Sheen, L.Y., 2009b. Cytotoxic activities of 9,11-dehydroergosterol peroxide and ergosterol peroxide from the fermentation mycelia of Ganoderma lucidum cultivated in the medium containing leguminous plants on Hep 3B cells. J. Agric. Food Chem. 57, 5713- 5719.
  • Chen, S., Xu, J., Liu, C., Zhu, Y., Nelson, D.R., Zhou, S., Li, C., Wang, L., Guo, X., Sun, Y., Luo, H., Li, Y., Song, J., Henrissat, B., Levasseur, A., Qian, J., Li, J., Luo, X., Shi, L., He, L., Xiang, L., Xu, X., Niu, Y., Li, Q., Han, M.V., Yan, H., Zhang, J., Chen, H., Lv, A., Wang, Z., Liu, M., Schwartz, D.C., Sun, C., 2012. Genome sequence of the model medicinal mushroom Ganoderma lucidum. Nat. Commun. 3, 913.
  • Cheng, C.R., Yue, Q.X., Wu, Z.Y., Song, X.Y., Tao, S.J., Wu, X.H., Xu, P.P., Liu, X., Guan, S.H., Guo, D.A., 2010. Cytotoxic triterpenoids from Ganoderma lucidum. Phytochemistry 71, 1579-1585.
  • de Silva, E.D., van der Sar, S.A., Santha, R.G., Wijesundera, R.L., Cole, A.L., Blunt, J.W., Munro, M.H., 2006. Lanostane triterpenoids from the Sri Lankan basidiomycete Ganoderma applanatum. J. Nat. Prod. 69, 1245-1248.
  • El Dine, R.S., El Halawany, A.M., Ma, C.M., Hattori, M., 2008a. Anti-HIV-1 protease activity of lanostane triterpenes from the Vietnamese mushroom Ganoderma colossum. J. Nat. Prod. 71, 1022-1026.
  • El Dine, R.S., El Halawany, A.M., Nakamura, N., Ma, C.M., Hattori, M., 2008b. New lanostane triterpene lactones from the Vietnamese mushroom Ganoderma colossum (FR.) C. F. BAKER. Chem. Pharm. Bull. 56, 642-646.
  • El Dine, R.S., El Halawany, A.M., Ma, C.M., Hattori, M., 2009. Inhibition of the dimerization and active site of HIV-1 protease by secondary metabolites from the Vietnamese mushroom Ganoderma colossum. J. Nat. Prod. 72, 2019-2023.
  • El-Mekkawy, S., Meselhy, M.R., Nakamura, N., Tezuka, Y., Hattori, M., Kakiuchi, N., Shimotohno, K., Kawahata, T., Otake, T., 1998. Anti-HIV-1 and anti-HIV-1 protease substances from Ganoderma lucidum. Phytochemistry 49, 1651-1657.
  • Eo, S.K., Kim, Y.S., Lee, C.K., Han, S.S., 1999a. Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum. J. Ethnopharmacol. 68, 129-136.
  • Eo, S.K., Kim, Y.S., Lee, C.K., Han, S.S., 1999b. Antiherpetic activities of various protein bound polysaccharides isolated from Ganoderma lucidum. J. Ethnopharmacol. 68, 175-181.
  • Fatmawati, S., Shimizu, K., Kondo, R., 2010. Ganoderic acid Df, a new triterpenoid with aldose reductase activity from the fruiting body of Ganoderma lucidum. Fitoterapia 81, 1033-1036.
  • Fujita, A., Arisawa, M., Saga, M., Hayashi, T., Morita, N., 1986. Two new lanostanoids from Ganoderma lucidum. J. Nat. Prod. 49, 1122-1125.
  • Fujita, R., Liu, J., Shimizu, K., Konishi, F., Noda, K., Kumamoto, S., Ueda, C., Tajiri, H., Kaneko, S., Suimi, Y., Kondo, R., 2005. Anti-androgenic activities of Ganoderma lucidum. J. Ethnopharmacol. 102, 107-112.
  • Fushimi, K., Horikawa, M., Suzuki, K., Sekiya, A., Kanno, S., Shimura, S., Kawagishi, H., 2010. Applanatines A-E from the culture broth of Ganoderma applanatum. Tetrahedron 66, 9332-9335.
  • Gan, K.H., Fann, Y.F., Hsu, S.H., Kuo, K.W., Lin, C.N., 1998a. Mediation of the cytotoxicity of lanostanoids and steroids of Ganoderma tsugae through apoptosis and cell cycle. J. Nat. Prod. 61, 485-487.
  • Gan, K.H., Kuo, S.H., Lin, C.N., 1998b. Steroidal constituents of Ganoderma applanatum and Ganoderma neo-japonicum. J. Nat. Prod. 61, 1421-1422.
  • Gao, J.J., Min, B.S., Ahn, E.M., Nakamura, N., Lee, H.K., Hattori, M., 2002. New triterpene aldehydes, lucialdehyde A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells. Chem. Pharm. Bull. 50, 837-840.
  • Gao, J.J., Nakamura, N., Min, B.S., Hirakawa, A., Zuo, F., Hattori, M., 2004. Quantitative determination of bitter principle in specimens of Ganoderma lucidum using high-performance liquid chromatography and its application to the evaluation of Ganoderma products. Chem. Pharm. Bull. 52, 688-695.
  • Gonzalez, A.G., Leon, F., Rivera, A., Munoz, C.M., Bermejo, J., 1999. Lanostanoid triterpenes from Ganoderma lucidum. J. Nat. Prod. 62, 1700-1701.
  • Gonzalez, A.G., Leon, F., Rivera, A., Padron, J.I., Gonzalez-Plata, J., Zuluaga, J.C., Quintana, J., Estevez, F., Bermejo, J., 2002. New lanostanoids from the fungus Ganoderma concinna. J. Nat. Prod. 65, 417-421.
  • Guan, S.H., Yang, M., Wang, X.M., Xia, J.M., Zhang, Z.M., Liu, X., Guo, D.A., 2007. Structure elucidation and complete NMR spectral assignments of three new lanostanoid triterpenes with unprecedented Δ16,17 double bond from Ganoderma lucidum. Magn. Reson. Chem. 45, 789-791.
  • Ha, T.B.T., Gerhauser, C., Zhang, W.D., Ho-Chong-Line, N., Fouraste, I., 2000. New lanostanoids from Ganoderma lucidum that induce NAD(P)H:qui-none oxidoreductase in cultured Hepalclc7 murine hepatoma cells. Planta Med. 66, 681-684.
  • Hajjaj, H., Mace, C., Roberts, M., Niederberger, P., Fay, L.B., 2005. Effect of 26- oxygenosterols from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors. Appl. Environ. Microbiol. 71, 3653-3658.
  • Hikino, H., Ishiyama, M., Suzuki, Y., Konno, C., 1989. Mechanisms of hypoglycaemic activity of ganoderan B: a glycan of Ganoderma lucidum fruit bodies. Planta Med. 55, 423-428.
  • Hill, R.A., Connolly, J.D., 2012. Triterpenoids. Nat. Prod. Rep. 29, 780-818.
  • Hill, R.A., Connolly, J.D., 2013. Triterpenoids. Nat. Prod. Rep. 30, 1028-1065.
  • Hirotani, M., Furuya, T., 1986. Ganoderic acid derivatives, highly oxygenated lanostane-type triterpenoids, from Ganoderma lucidum. Phytochemistry 25, 1189-1193.
  • Hirotani, M., Furuya, T., Shiro, M., 1985. A ganoderic acid derivative, a highly oxygenated lanostane-type triterpenoid from Ganoderma lucidum. Phytochemistry 24, 2055-2061.
  • Hirotani, M., Ino, C., Furuya, T., Shiro, M., 1986. Ganoderic acids T, S and R, new triterpenoids from the cultured mycelium of Ganoderma lucidum. Chem. Pharm. Bull. 34, 2282-2285.
  • Hirotani, M., Asaka, I., Ino, C., Furuya, T., Shiro, M., 1987. Ganoderic acid derivatives and ergosta-4,7,22-triene-3,6-dione from Ganoderma lucidum. Phytochemistry 26, 2797-2803.
  • Hirotani, M., Furuya, T., Shiro, M., 1991. Cryptoporic acids H and I, drimane sesquiterpenes from Ganoderma neo-japonicum and Cryptoporus volvatus. Phytochemistry 30, 1555-1559.
  • Hirotani, M., Ino, C., Furuya, T., 1993. Comparative study on the strain-specific triterpenoid components of Ganoderma lucidum. Phytochemistry 33, 379-382.
  • Hirotani, M., Ino, C., Hatano, A., Takayanagi, H., Furuya, T., 1995. Ganomastenols A, B, C and D, cadinene sesquiterpenes, from Ganoderma mastoporum. Phytochemistry 40, 161-165.
  • Hu, L.L., Ma, Q.Y., Huang, S.Z., Guo, Z.K., Ma, H.X., Guo, J.C., Dai, H.F., Zhao, Y.X., 2013. Three new lanostanoid triterpenes from the fruiting bodies of Ganoderma tropicum. J. Asian Nat. Prod. Res. 15, 357-362.
  • Hu, L.L., Ma, Q.Y., Huang, S.Z., Guo, Z.K., Ma, H.X., Guo, J.C., Dai, H.F., Zhao, Y.X., 2014. A new nortriterpenoid from the fruiting bodies of Ganoderma tropicum. Phytochem. Lett. 7, 11-13.
  • Isaka, M., Chinthanom, P., Kongthong, S., Srichomthong, K., Choeyklin, R., 2013. Lanostane triterpenes from cultures of the basidiomycete Ganoderma orbiforme BCC 22324. Phytochemistry 87, 133-139.
  • Iwatsuki, K., Akihisa, T., Tokuda, H., Ukiya, M., Oshikubo, M., Kimura, Y., Asano, T., Nomura, A., Nishino, H., 2003. Lucidenic acid P and Q, methyl lucidenate P and other triterpenoids from the fungus Ganoderma lucidum and their inhibitory effects on Epstein-Barr Virus activation. J. Nat. Prod. 66, 1582-1585.
  • Jain, A.C., Gupta, S.K., 1984. The isolation of lanosta-7,9(11),24-trien-3β,21-diol from the fungus Ganoderma australe. Phytochemistry 23, 686-687.
  • Jin-Ming, G., 2006. New biologically active metabolites from Chinese higher fungi. Curr. Org. Chem. 10, 849-871.
  • Jonathan, S.G., Kigigha, L.T., Ohimain, E., 2008. Evaluation of the inhibitory potentials of eight higher Nigerian fungi against pathogenic microorganisms. Afr. J. Biomed. Res. 11, 197-202.
  • Jong, S.C., Birmingham, J.M., 1992. Medicinal benefits of the mushroom Ganoderma. Adv. Appl. Microbiol. 37, 101-134.
  • Joseph, S., Sabulal, B., George, V., Smina, T.P., Janardhanan, K.K., 2009. Antioxidative and antiinflammatory activities of the chloroform extract of Ganoderma lucidum found in south India. Sci. Pharm. 77, 111-121.
  • Joseph, S., Janardhanan, K.K., George, V., Sabulal, B., 2011a. A new epoxidic ganoderic acid and other phytoconstituents from Ganoderma lucidum. Phytochem. Lett. 4, 386-388.
  • Joseph, S., Sabulal, B., George, V., Antony, K.R., Janardhanan, K.K., 2011b. Antitumor and anti-inflammatory activities of polysaccharides isolated from Ganoderma lucidum. Acta Pharm. 61, 335-342.
  • Jung, M., Liermann, J.C., Opatz, T., Erkel, G., 2011. Ganodermycin, a novel inhibitor of CXCL10 expression from Ganoderma applanatum. J. Antibiot. 64, 683-686.
  • Keller, A.C., Keller, J., Maillard, M.P., Hostettmann, K., 1997. A lanostane-type steroid from the fungus Ganoderma carnosum. Phytochemistry 46, 963-965.
  • Kikuchi, T., Matsuda, S., Kadota, S., Murai, Y., Ogita, Z.I., 1985a. Ganoderic acid D, E, F and H and lucidenic acid D, E and F, new triterpenoids from Ganoderma lucidum. Chem. Pharm. Bull. 33, 2624-2627.
  • Kikuchi, T., Matsuda, S., Murai, Y., Ogita, Z., 1985b. Ganoderic acid G and I and ganolucidic acid A and B, new triterpenoids from Ganoderma lucidum. Chem. Pharm. Bull. 33, 2628-2631.
  • Kikuchi, T., Kanomi, S., Kadota, S., Murai, Y., Tsubono, K., Ogita, Z.I., 1986a. Constituents of the fungus Ganoderma lucidum (FR.) KARST. I. Structures of ganoderic acids C2, E, I, and K, lucidenic acid F and related compounds. Chem. Pharm. Bull. 34, 3695-3712.
  • Kikuchi, T., Kanomi, S., Murai, Y., Kadota, S., Tsubono, K., Ogita, Z.I., 1986b. Constituents of the fungus Ganoderma lucidum (FR.) KARST. II. Structures of ganoderic acids F, G and H, lucidenic acids D2 and E2, and related compounds. Chem. Pharm. Bull. 34, 4018-4029.
  • Kikuchi, T., Kanomi, S., Murai, Y., Kadota, S., Tsubono, K., Ogita, Z.I., 1986c. Constituents of the fungus Ganoderma lucidum (Fr.) Karst. III. Structure of ganolucidic acids A and B, new lanostane-type triterpenoids. Chem. Pharm. Bull. 34, 4030-4036.
  • Kim, H.W., Kim, B.K., 1999. Biomedicinal triterpenoids of Ganoderma lucidum (Curt.:Fr.) P. Karst. (Aphyllophoromycetideae). Int. J. Med. Mushrooms 1, 121-138.
  • Kim, M.J., Kim, H.W., Lee, Y.S., Shim, M.J., Choi, E.C., Kim, B.K., 1986. Studies on safety of Ganoderma lucidum. Korean J. Mycol. 14, 49-59.
  • Kim, D.H., Shim, S.B., Kim, N.J., Jang, I.S., 1999. Beta-glucuronidase-inhibitory activity and hepatoprotective effect of Ganoderma lucidum. Biol. Pharm. Bull. 22, 162-164.
  • Kimura, Y., Taniguchi, M., Baba, K., 2002. Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance. Anticancer Res. 22, 3309-3318.
  • Kleinwachter, P., Anh, N., Kiet, T.T., Schlegel, B., Dahse, H.M., Hartl, A., Grafe, U., 2001. Colossolactones, new triterpenoid metabolites from a Vietnamese mushroom Ganoderma colossum. J. Nat. Prod. 64, 236-239.
  • Ko, H.H., Hung, C.F., Wang, J.P., Lin, C.N., 2008. Antiinflammatory triterpenoids and steroids from Ganoderma lucidum and G. tsugae. Phytochemistry 69, 234-239.
  • Kohda, H., Tokumoto, W., Sakamoto, K., Fujii, M., Hirai, Y., Yamasaki, K., Komoda, Y., Nakamura, H., Ishihara, S., Uchida, M., 1985. The biologically active constituents of Ganoderma lucidum (Fr.) Karst. Histamine release-inhibitory triterpenes. Chem. Pharm. Bull. 33, 1367-1374.
  • Komoda, Y., Nakamura, H., Ishihara, S., Uchida, M., Kohda, H., Yamasaki, K., 1985. Structures of new triterpenoid constituents of Ganoderma lucidum (Fr.) Karst (Polyporaceae). Chem. Pharm. Bull. 33, 4829-4835.
  • Komoda, Y., Shimizu, M., Sonoda, Y., Sato, Y., 1989. Ganoderic acid and its derivatives as cholesterol synthesis inhibitors. Chem. Pharm. Bull. 37, 531-533.
  • Koyama, K., Imaizumi, T., Akiba, M., Kinoshita, K., Takahashi, K., Suzuki, A., Yano, S., Horie, S., Watanabe, K., Naoi, Y., 1997. Antinociceptive components of Ganoderma lucidum. Planta Med. 63, 224-227.
  • Kubota, T., Asaka, Y., Miura, I., Mori, H., 1982. Structures of ganoderic acid A and B, two new type bitter triterpenes from Ganoderma lucidum (Fr.) Karst. Helv. Chim. Acta 65, 611-619.
  • La Clair, J.J., Rheingold, A.L., Burkart, M.D., 2011. Ganodone, a bioactive benzofuran from the fruiting bodies of Ganoderma tsugae. J. Nat. Prod. 74, 2045-2051.
  • Lakornwong, W., Kanokmedhakul, K., Kanokmedhakul, S., Kongsaeree, P., Prabpai, S., Sibounnavong, P., Soytong, K., 2014. Triterpene lactones from cultures of Ganoderma sp. KM01. J. Nat. Prod. 77, 1545-1553.
  • Lee, S., Park, S., Oh, J.W., Yang, C., 1998. Natural inhibitors for protein prenyltransferase. Planta Med. 64, 303-308.
  • Lee, J.M., Kwon, H., Jeong, H., Lee, J.W., Lee, S.Y., Baek, S.J., Surh, Y.J., 2001. Inhibition of lipid peroxidation and oxidative DNA damage by Ganoderma lucidum. Phytother. Res. 15, 245-249.
  • Lee, S., Shim, S.H., Kim, J.S., Shin, K.H., Kang, S.S., 2005. Aldose reductase inhibitors from the fruiting bodies of Ganoderma applanatum. Biol. Pharm. Bull. 28, 1103-1105.
  • Lee, S.H., Shim, S.H., Kim, J.S., Kang, S.S., 2006. Constituents from the fruiting bodies of Ganoderma applanatum and their aldose reductase inhibitory activity. Arch. Pharm. Res. 29, 479-483.
  • Lee, I., Kim, H., Youn, U., Kim, J., Min, B., Jung, H., Na, M., Hattori, M., Bae, K., 2010a. Effect of lanostane triterpenes from the fruiting bodies of Ganoderma lucidum on adipocyte differentiation in 3T3-L1 cells. Planta Med. 76, 1558-1563.
  • Lee, I., Seo, J., Kim, J., Kim, H., Youn, U., Lee, J., Jung, H., Na, M., Hattori, M., Min, B., Bae, K., 2010b. Lanostane triterpenes from the fruiting bodies of Ganoderma lucidum and their inhibitory effects on adipocyte differentiation in 3T3-L1 cells. J. Nat. Prod. 73, 172-176.
  • Lee, I., Ahn, B., Choi, J., Hattori, M., Min, B., Bae, K., 2011a. Selective cholinesterase inhibition by lanostane triterpenes from fruiting bodies of Ganoderma lucidum. Bioorg. Med. Chem. Lett. 21, 6603-6607.
  • Lee, S.Y., Kim, J.S., Lee, S., Kang, S.S., 2011b. Polyoxygenated ergostane-type sterols from the liquid culture of Ganoderma applanatum. Nat. Prod. Res. 25, 1304- 1311.
  • Leon, F., Valencia, M., Rivera, A., Nieto, I., Quintana, J., Estevez, F., Bermejo, J., 2003. Novel cytostatic lanostanoid triterpenes from Ganoderma australe. Helv. Chim. Acta 86, 3088-3095.
  • Leung, S.W.S., Yeung, K.Y., Ricky, Y.L.S., Man, Y.K., 2002. Lingzhi (Ganoderma) research: the past, present and future perspectives. In: Lin, Z.B. (Ed.), Ganoderma: Genetics, Chemistry, Pharmacology and Therapeutics. Beijing Medical University Press, Beijing, pp. 1-9.
  • Li, C.H., Chen, P.Y., Chang, U.M., Kan, L.S., Fang, W.H., Tsai, K.S., Lin, S.B., 2005a. Ganoderic acid X, a lanostanoid triterpene, inhibits topoisomerases and induces apoptosis of cancer cells. Life Sci. 77, 252-265.
  • Li, C., Yin, J., Guo, F., Zhang, D., Sun, H.H., 2005b. Ganoderic acid Sz, a new lanostanoid from the mushroom Ganoderma lucidum. Nat. Prod. Res. 19, 461- 465.
  • Li, C., Li, Y., Sun, H.H., 2006. New ganoderic acids, bioactive triterpenoid metabolites from the mushroom Ganoderma lucidum. Nat. Prod. Res. 20, 985-991.
  • Li, Y.-Y., Mi, Z.-Y., Tang, Y., Wang, G., Li, D.-S., Tang, Y.-J., 2009. Lanostanoids isolated from Ganoderma lucidum mycelium cultured by submerged fermentation. Helv. Chim. Acta 92, 1586-1593.
  • Li, J., Zhang, J., Chen, H., Chen, X., Lan, J., Liu, C., 2013a. Complete mitochondrial genome of the medicinal mushroom Ganoderma lucidum. PLoS One 8, e72038.
  • Li, P., Deng, Y.P., Wei, X.X., Xu, J.H., 2013b. Triterpenoids from Ganoderma lucidum and their cytotoxic activities. Nat. Prod. Res. 27, 17-22.
  • Li, Y.B., Liu, R.M., Zhong, J.J., 2013c. A new ganoderic acid from Ganoderma lucidum mycelia and its stability. Fitoterapia 84, 115-122.
  • Liang, C.X., Li, Y.B., Xu, J.W., Wang, J.L., Miao, X.L., Tang, Y.J., Gu, T., Zhong, J.J., 2010. Enhanced biosynthetic gene expressions and production of ganoderic acids in static liquid culture of Ganoderma lucidum under phenobarbital induction. Appl. Microbiol. Biotechnol. 86, 1367-1374.
  • Liew, C.W., Lee, S.S., Wang, S.Y., 1992. The effect of Ganoderma lucidum on induction of differentiation in leukemia U937 cells. Anticancer Res. 12, 1211-1216.
  • Lin, L.J., Shiao, M.S., Yeh, S.F., 1988a. Seven new triterpenes from Ganoderma lucidum. J. Nat. Prod. 51, 918-924.
  • Lin, L.J., Shiao, M.S., Yeh, S.F., 1988b. Triterpenes from Ganoderma lucidum. Phytochemistry 27, 2269-2271.
  • Lin, C.N., Tome, W.P., Won, S.J., 1990. A lanostanoid of formosan Ganoderma lucidum. Phytochemistry 29, 673-675.
  • Lin, C.N., Tome, W.P., Won, S.J., 1991. Novel cytotoxic principles of Formosan Ganoderma lucidum. J. Nat. Prod. 54, 998-1002.
  • Lin, C.N., Kuo, S.H., Won, S.J., 1993. Steroids of formosan Ganoderma amboinense. Phytochemistry 32, 1549-1551.
  • Lin, J.M., Lin, C.C., Chen, M.F., Ujiie, T., Takada, A., 1995. Radical scavenger and antihepatotoxic activity of Ganoderma formosanum, Ganoderma lucidum and Ganoderma neo-japonicum. J. Ethnopharmacol. 47, 33-41.
  • Lin, C.N., Fann, Y.F., Chung, M.I., 1997. Steroids of formosan Ganoderma tsugae. Phytochemistry 46, 1143-1146.
  • Lin, S.B., Li, C.H., Lee, S.S., Kan, L.S., 2003. Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinase and G2-phase cell cycle arrest. Life Sci. 72, 2381-2390.
  • Lin, K.W., Chen, Y.T., Yang, S.C., Wei, B.L., Hung, C.F., Lin, C.N., 2013. Xanthine oxidase inhibitory lanostanoids from Ganoderma tsugae. Fitoterapia 89, 231- 238.
  • Liu, J., Shimizi, K., Kondo, R., 2006. Ganoderic acid TR, a new lanostanoid with 5OE- reductase inhibitory activity from the fruiting body of Ganoderma lucidum. Nat. Prod. Commun. 1, 345-350.
  • Liu, J., Shimizu, K., Konishi, F., Noda, K., Kumamoto, S., Kurashiki, K., Kondo, R., 2007. Antiandrogenic activities of the triterpenoids fraction of Ganoderma lucidum. Food Chem. 100, 1691-1696.
  • Liu, Y.W., Gao, J.L., Guan, J., Qian, Z.M., Feng, K., Li, S.P., 2009a. Evaluation of antiproliferative activities and action mechanisms of extracts from two species of Ganoderma on tumor cell lines. J. Agric. Food Chem. 57, 3087-3093.
  • Liu, D., Hu, Z., Liu, Z., Yang, B., Tu, W., Li, L., 2009b. Chemical composition and antimicrobial activity of essential oil isolated from the cultured mycelia of Ganoderma japonicum. J. Nanjing Med. Univ. 23, 168-172.
  • Liu, C., Zhao, F., Chen, R., 2010. A novel alkaloid from the fruiting bodies of Ganoderma sinense Zhao, Xu et Zhang. Chin. Chem. Lett. 21, 197-199.
  • Liu, J.Q., Wang, C.F., Peng, X.R., Qiu, M.H., 2011. New alkaloids from the fruiting bodies of Ganoderma sinense. Nat. Prod. Bioprospect. 1, 93-96.
  • Liu, J., Shimizu, K., Tanaka, A., Shinobu, W., Ohnuki, K., Nakamura, T., Kondo, R., 2012a. Target proteins of ganoderic acid DM provides clues to various pharmacological mechanisms. Sci. Rep. 2, 905.
  • Liu, J.Q., Wang, C.F., Li, Y., Luo, H.R., Qiu, M.H., 2012b. Isolation and bioactivity evaluation of terpenoids from the medicinal fungus Ganoderma sinense. Planta Med. 78, 368-376.
  • Liu, D.Z., Zhu, Y.Q., Li, X.F., Shan, W.G., Gao, P.F., 2014a. New triterpenoids from the fruiting bodies of Ganoderma lucidum and their bioactivities. Chem. Biodivers. 11, 982-986.
  • Liu, L.Y., Chen, H., Liu, C., Wang, H.Q., Kang, J., Li, Y., Chen, R.Y., 2014b. Triterpenoids of Ganoderma theaecolum and their hepatoprotective activities. Fitoterapia 98, 254-259.
  • Luo, J., Zhao, Y.Y., Lin, Z.B., 2002. A new lanostane-type triterpene from the fruiting bodies of Ganoderma lucidum. J. Asian Nat. Prod. Res. 4, 129-134.
  • Ma, J., Ye, Q., Hua, Y., Zhang, D., Cooper, R., Chang, M.N., Chang, J.Y., Sun, H.H., 2002. New lanostanoids from the mushroom Ganoderma lucidum. J. Nat. Prod. 65, 72-75.
  • Ma, B.J., Zhou, Y., Ruan, Y., Ma, J.C., Ren, W., Wen, C.N., 2012. Lanostane-type triterpenes from the sporoderm-broken spores of Ganoderma lucidum. J. Antibiot. 65, 165-167.
  • Ma, Q.Y., Luo, Y., Huang, S.Z., Guo, Z.K., Dai, H.F., Zhao, Y.X., 2013. Lanostane triterpenoids with cytotoxic activities from the fruiting bodies of Ganoderma hainanense. J. Asian Nat. Prod. Res. 15, 1214-1219.
  • Ma, K., Ren, J., Han, J., Bao, L., Li, L., Yao, Y., Sun, C., Zhou, B., Liu, H., 2014. Ganoboninketals A-C, antiplasmodial 3,4-seco-27-norlanostane triterpenes from Ganoderma boninense Pat. J. Nat. Prod. 77, 1847-1852.
  • Mahato, S.B., Kundu, A.P., 1994. 13C NMR spectra of pentacyclic triterpenoids - a compilation and some salient features. Phytochemistry 37, 1517-1575.
  • Mau, J.L., Tsai, S.Y., Tseng, Y.H., Huang, S.J., 2005. Antioxidant properties of methanolic extracts from Ganoderma tsugae. Food Chem. 93, 641-649.
  • Min, B.S., Nakamura, N., Miyashiro, H., Bae, K.W., Hattori, M., 1998. Triterpenes from the spores of Ganoderma lucidum and their inhibitory effect against HIV-1 protease. Chem. Pharm. Bull. 46, 1607-1612.
  • Min, B.S., Gao, J.J., Nakamura, N., Hattori, M., 2000. Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem. Pharm. Bull. 48, 1026-1033.
  • Min, B.S., Gao, J.J., Hattori, M., Lee, H.K., Kim, Y.H., 2001. Anticomplement activity of terpenoids from the spores of Ganoderma lucidum. Planta Med. 67, 811-814.
  • Ming, D., Chilton, J., Fogarty, F., Towers, G.H., 2002. Chemical constituents of Ganoderma applanatum of British Columbia forests. Fitoterapia 73, 147-152.
  • Mizushina, Y., Hanashima, L., Yamaguchi, T., Takemura, M., Sugawara, F., Saneyoshi, M., Matsukage, A., Yoshida, S., Sakaguchi, K., 1998a. A mushroom fruiting bodyinducing substance inhibits activities of replicative DNA polymerases. Biochem. Biophys. Res. Commun. 249, 17-22.
  • Mizushina, Y., Watanabe, I., Togashi, H., Hanashima, L., Takemura, M., Ohta, K., Sugawara, F., Koshino, H., Esumi, Y., Uzawa, J., Matsukage, A., Yoshida, S., Sakaguchi, K., 1998b. An ergosterol peroxide, a natural product that selectively enhances the inhibitory effect of linoleic acid on DNA polymerase β. Biol. Pharm. Bull. 21, 444-448.
  • Mizushina, Y., Takahashi, N., Hanashima, L., Koshino, H., Esumi, Y., Uzawa, J., Suqawara, F., Sakaquchi, K., 1999. Lucidenic acid O and lactone, new terpene inhibitors of eukaryotic DNA polymerases from a basidiomycete, Ganoderma lucidum. Bioorg. Med. Chem. 7, 2047-2052.
  • Morigiwa, A., Kitabatake, K., Fujimoto, Y., Ikekawa, N., 1986. Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum. Chem. Pharm. Bull. 34, 3025-3028.
  • Mothana, R.A.A., Jansen, R., Julich, W.D., Lindequist, U., 2000. Ganomycins A and B, new antimicrobial farnesyl hydroquinones from the basidiomycete Ganoderma pfeifferi. J. Nat. Prod. 63, 416-418.
  • Mothana, R.A.A., Awadh Ali, N.A., Jansen, R., Wegner, U., Mentel, R., Lindequist, U., 2003. Antiviral lanostanoid triterpenes from the fungus Ganoderma pfeifferi. Fitoterapia 74, 177-180.
  • Muller, C.I., Kumagai, T., Okelly, J., Seeram, N.P., Heber, D., Koeffler, H.P., 2006. Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. Leuk. Res. 30, 841-848.
  • Ngai, P.H.K., Ng, T.B., 2004. A mushroom (Ganoderma capense) lectin with spectacular thermostability, potent mitogenic activity on splenocytes and antiproliferative activity toward tumor cells. Biochem. Biophys. Res. Commun. 314, 988-993.
  • Niedermeyer, T.H.J., Lindequist, U., Mentel, R., Gordes, D., Schmidt, E., Thurow, K., Lalk, M., 2005. Antiviral terpenoid constituents of Ganoderma pfeifferi. J. Nat. Prod. 68, 1728-1731.
  • Niedermeyer, T.H.J., Jira, T., Lalk, M., Lindequist, U., 2013. Isolation of farnesylhydroquinones from the basidiomycete Ganoderma pfeifferi. Nat. Products Bioprospect. 3, 137-140.
  • Nishitoba, T., Sato, H., Kasai, T., Kawagishi, H., Sakamura, S., 1984. New bitter C27 and C30 terpenoids from the fungus Ganoderma lucidum (Reishi). Agric. Biol. Chem. 48, 2905-2907.
  • Nishitoba, T., Sato, H., Sakamura, S., 1985a. New terpenoids from Ganoderma lucidum and their bitterness. Agric. Biol. Chem. 49, 1547-1549.
  • Nishitoba, T., Sato, H., Sakamura, S., 1985b. New terpenoids, ganoderic acid J and ganolucidic acid C, from the fungus Ganoderma lucidum. Agric. Biol. Chem. 49, 3637-3638.
  • Nishitoba, T., Sato, H., Kasai, T., Kawagishi, H., Sakamura, S., 1985c. New bitter C27 and C30 terpenoids from the fungus Ganoderma lucidum (Reishi). Agric. Biol. Chem. 49, 1793-1798.
  • Nishitoba, T., Sato, H., Sakamura, S., 1986a. New terpenoids, ganolucidic acid D, ganoderic acid L, lucidone C and lucidenic acid G, from the fungus Ganoderma lucidum. Agric. Biol. Chem. 50, 809-811.
  • Nishitoba, T., Sato, H., Shirasu, S., Sakamura, S., 1986b. Evidence on the strain-specific terpenoid pattern of Ganoderma lucidum. Agric. Biol. Chem. 50, 2151- 2154.
  • Nishitoba, T., Sato, H., Shirasu, S., Sakamura, S., 1987a. Novel triterpenoids from the mycelia mat at the previous stage of fruiting of Ganoderma lucidum. Agric. Biol. Chem. 51, 619-622.
  • Nishitoba, T., Sato, H., Sakamura, S., 1987b. Novel mycelia components, Ganoderic acid Mg, Mh, Mi, Mj and Mk, from the fungus Ganoderma lucidum. Agric. Biol. Chem. 51, 1149-1153.
  • Nishitoba, T., Sato, H., Sakamura, S., 1987c. Triterpenoids from the fungus Ganoderma lucidum. Phytochemistry 26, 1777-1784.
  • Nishitoba, T., Oda, K., Sato, H., Sakamura, S., 1988a. Novel triterpenoids from the fungus Ganoderma lucidum. Agric. Biol. Chem. 52, 367-372.
  • Nishitoba, T., Sato, H., Oda, K., Sakamura, S., 1988b. Novel triterpenoids and a steroid from the fungus Ganoderma lucidum. Agric. Biol. Chem. 52, 211-216.
  • Nishitoba, T., Goto, S., Sato, H., Sakamura, S., 1989. Bitter triterpenoids from the fungus Ganoderma applanatum. Phytochemistry 28, 193-197.
  • Niu, X., Qiu, M., Li, Z., Lu, Y., Cao, P., Zheng, Q., 2004. Two novel 3,4-seco - trinorlanostane triterpenoids isolated from Ganoderma fornicatum. Tetrahedron Lett. 45, 2989-2993.
  • Niu, X.M., Li, S.H., Sun, H.D., Che, C.T., 2006. Prenylated phenolics from Ganoderma fornicatum. J. Nat. Prod. 69, 1364-1365.
  • Niu, X.M., Li, S.H., Xiao, W.L., Sun, H.D., Che, C.T., 2007. Two new lanostanoids from Ganoderma resinaceum. J. Asian Nat. Prod. Res. 9, 659-664.
  • Ofodile, L.N., Uma, N., Grayer, R.J., Ogundipe, O.T., Simmonds, M.S.J., 2012. Antibacterial compounds from the mushroom Ganoderma colossum from Nigeria. Phytother. Res. 26, 748-751.
  • Paterson, R.R.M., 2006. Ganoderma - a therapeutic fungal biofactory. Phytochemistry 67, 1985-2001.
  • Peng, X.R., Liu, J.Q., Han, Z.H., Yuan, X.X., Luo, H.R., Qiu, M.H., 2013. Protective effects of triterpenoids from Ganoderma resinaceum on H2O2-induced toxicity in HepG2 cells. Food Chem. 141, 920-926.
  • Peng, X.R., Liu, J.Q., Wan, L.S., Li, X.N., Yan, Y.X., Qiu, M.H., 2014a. Four new polycyclic meroterpenoids from Ganoderma cochlear. Org. Lett. 16, 5262-5265.
  • Peng, X.R., Liu, J.Q., Wang, C.F., Li, X.Y., Shu, Y., Zhou, L., Qiu, M.H., 2014b. Hepatoprotective effects of triterpenoids from Ganoderma cochlear. J. Nat. Prod. 77, 737-743.
  • Qiao, Y., Zhang, X.M., Dong, X.C., Qiu, M.H., 2006. A new 18(13 + 12β)-abeolanostadiene triterpenoid from Ganoderma fornicatum. Helv. Chim. Acta 89, 1038-1041.
  • Qiao, Y., Zhang, X.M., Qiu, M.H., 2007. Two novel lanostane triterpenoids from Ganoderma sinense. Molecules 12, 2038-2046.
  • Richter, C., Wittstein, K., Kirk, P.M., Stadler, M., 2015. An assessment of the taxonomy and chemotaxonomy of Ganoderma. Fungal Divers. 71, 1-15.
  • Rios, J.L., Andujar, I., Recio, M.C., Giner, R.M., 2012. Lanostanoids from fungi: a group of potential anticancer compounds. J. Nat. Prod. 75, 2016-2044.
  • Rosecke, J., Konig, W.A., 2000. Constituents of various wood-rotting basidiomycetes. Phytochemistry 54, 603-610.
  • Sanodiya, B.S., Thakur, G.S., Baghel, R.K., Prasad, G.B., Bisen, P.S., 2009. Ganoderma lucidum: a potent pharmacological macrofungus. Curr. Pharm. Biotechnol. 10, 717-742.
  • Sato, H., Nishitoba, T., Shirasu, S., Oda, K., Sakamura, S., 1986. Ganderiol A and B, new triterpenoids from the fungus Ganoderma lucidum (Reishi). Agric. Biol. Chem. 50, 2887-2890.
  • Sato, N., Ma, C.M., Komatsu, K., Hattori, M., 2009a. Triterpene-farnesyl hydroquinone conjugates from Ganoderma sinense. J. Nat. Prod. 72, 958-961.
  • Sato, N., Zhang, Q., Ma, C.M., Hattori, M., 2009b. Anti-human immunodeficiency virus-1 protease activity of new lanostane-type triterpenoids from Ganoderma sinense. Chem. Pharm. Bull. 57, 1076-1080.
  • Seo, G.S., Kirk, P.M., 2000. Ganodermataceae: nomenclature and classification. In: Flood, J., Bridge, P.D., Holderness, P. (Eds.), Ganoderma Disease of Perennial Crops. CABI Publishing, Wallingford, UK, pp. 3-22.
  • Seo, H.W., Hung, T.M., Na, M., Jung, H.J., Kim, J.C., Choi, J.S., Kim, J.H., Lee, H.K., Lee, I., Bae, K., Hattori, M., Min, B.S., 2009. Steroids and triterpenes from the fruit bodies of Ganoderma lucidum and their anti-complement activity. Arch. Pharm. Res. 32, 1573-1579.
  • Shi, L., Ren, A., Mu, D., Zhao, M., 2010. Current progress in the study on biosynthesis and regulation of ganoderic acids. Appl. Microbiol. Biotechnol. 88, 1243-1251.
  • Shiao, M.S., 2003. Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions. Chem. Rec. 3, 172-180.
  • Shiao, M.S., Lin, L.J., Yeh, S.F., Chou, C.S., 1987. Two new triterpenes of the fungus Ganoderma lucidum. J. Nat. Prod. 50, 886-890.
  • Shiao, M.S., Lin, L.J., Yeh, S.F., 1988a. Triterpenes in Ganoderma lucidum. Phytochemistry 27, 873-875.
  • Shiao, M.S., Lin, L.J., Yeh, S.F., 1988b. Triterpenes from Ganoderma lucidum. Phytochemistry 27, 2911-2914.
  • Shie, Y.H., Liu, C.F., Huang, Y.K., Yang, J.Y., Wu, I.L., Lin, C.H., Li, S.C., 2001. Evaluation of the hepatic and renal protective effects of Ganoderma lucidum in mice. Am. J. Chin. Med. 29, 501-507.
  • Shim, S.H., Ryu, J., Kim, J.S., Kang, S.S., Xu, Y., Jung, S.H., Lee, Y.S., Lee, S., Shin, K.H., 2004. New lanostane-type triterpenoids from Ganoderma applanatum. J. Nat. Prod. 67, 1110-1113.
  • Smania Jr., A., Monache, F.D., Smania, E.F.A., Cuneo, R.S., 1999. Antibacterial activity of steroidal compounds isolated from Ganoderma applanatum (Pers.) Pat. (Aphyllophoromycetideae) fruit body. Int. J. Med. Mushrooms 1, 325-330.
  • Smania, E.F.A., Monache, F.D., Smania Jr., A., Yunes, R.A., Cuneo, R.S., 2003. Antifungal activity of sterols and triterpenes isolated from Ganoderma annulare. Fitoterapia 74, 375-377.
  • Smania, E.F.A., Monache, F.D., Yunes, R.A., Paulert, R., Smania Jr., A., 2007. Antimicrobial activity of methyl australate from Ganoderma australe. Braz. J. Pharmacog. 17, 14-16.
  • Sonoda, Y., Sekigawa, Y., Sato, Y., 1988. In vitro effects of oxygenated lanosterol derivatives on cholesterol biosynthesis from 24,25-dihydrolanosterol. Chem. Pharm. Bull. 36, 966-973.
  • Strigina, L.I., Elkin, Y.N., Elyakov, G.B., 1971. Steroid metabolites of Ganoderma applanatum basidiomycete. Phytochemistry 10, 2361-2365.
  • Su, H.J., Fann, Y.F., Chung, M.I., Won, S.J., Lin, C.N., 2000. New lanostanoids of Ganoderma tsugae. J. Nat. Prod. 63, 514-516.
  • Toth, J.O., Luu, B., Beck, J.-P., Ourisson, G., 1983a. Chemistry and biochemistry of oriental drugs. Part IX. Cytotoxic triterpenes from Ganoderma lucidum (Polyporaceae): structures of ganoderic acids U-Z. J. Chem. Res., 2722-2787
  • Toth, J.O., Luu, B., Ourisson, G., 1983b. Ganoderic acid T and Z: cytotoxic triterpenes from Ganoderma lucidum. Tetrahedron Lett. 24, 1081-1084.
  • Toth, J.O., Luu, B., Beck, J.P., Ourisson, G., 1983c. Bitter triterpenoids from the fungus Ganoderma lucidum. J. Chem. Res., 2792-2795
  • Tung, N.T., Cuong, T.D., Hung, T.M., Lee, J.H., Woo, M.H., Choi, J.S., Kim, J., Ryu, S.H., Min, B.S., 2013. Inhibitory effect on NO production of triterpenes from the fruiting bodies of Ganoderma lucidum. Bioorg. Med. Chem. Lett. 23, 1428-1432.
  • Wagner, R., Mitchell, D.A., Sassaki, G.L., Amazonas, M.A.L.D., Berovic, M., 2003. Current techniques for the cultivation of Ganoderma lucidum for the production of biomass, ganoderic acid and polysaccharides. Food Technol. Biotechnol. 41, 371-382.
  • Wang, F., Liu, J.K., 2008. Highly oxygenated lanostane triterpenoids from the fungus Ganoderma applanatum. Chem. Pharm. Bull. 56, 1035-1037.
  • Wang, G., Zhang, J., Mizuno, T., Zhuang, C., Ito, H., Mayuzumi, H., Okamoto, H., Li, J., 1993. Antitumor active polysaccharides from the Chinese mushroom Songshan Lingzhi, the fruiting body of Ganoderma tsugae. Biosci. Biotechnol. Biochem. 57, 894-900.
  • Wang, F.S., Cai, H., Yang, J.S., Zhang, Y.M., Hou, C.Y., Liu, J.Q., Zhao, M.J., 1997a. Studies on the ganoderic acid, a new constituents from the fruiting body of Ganoderma lucidum (Fr.) Karst. Yao Xue Xue Bao 32, 447-450.
  • Wang, F.S., Cai, H., Yang, J.S., Zhang, Y.M., Zhao, Y.J., 1997b. Triterpenoids from the fruiting body of Ganoderma lucidum. JCPS (J. Chin. Pharm. Sci.) 6, 192-197.
  • Wang, X.M., Yang, M., Guan, S.H., Liu, R.X., Xia, J.M., Bi, K.S., Guo, D.A., 2006. Quantitative determination of six major triterpenoids in Ganoderma lucidum and related species by high performance liquid chromatography. J. Pharm. Biomed. Anal. 41, 838-844.
  • Wang, C.F., Liu, J.Q., Yan, Y.X., Chen, J.C., Lu, Y., Guo, Y.H., Qiu, M.H., 2010a. Three new triterpenoids containing four-membered ring from the fruiting body of Ganoderma sinense. Org. Lett. 12, 1656-1659.
  • Wang, J.L., Li, Y.B., Liu, R.M., Zhong, J.J., 2010b. A new ganoderic acid from Ganoderma lucidum mycelia. J. Asian Nat. Prod. Res. 12, 727-730.
  • Wasser, S.P., 2005. Reishi or Ling Zhi (Ganoderma lucidum), Encyclopedia of Dietary Supplements. Marcel Dekker, New York, USA, pp. 603-622.
  • Wasser, S.P., Weis, A.L., 1999. Therapeutic effects of substance occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit. Rev. Immunol. 19, 65- 96.
  • Weng, Y., Xiang, L., Matsuura, A., Zhang, Y., Huang, Q., Qi, J., 2010. Ganodermasides A and B, two novel anti-aging ergosterols from spores of a medicinal mushroom Ganoderma lucidum on yeast via UTH1 gene. Bioorg. Med. Chem. 18, 999-1002.
  • Weng, Y., Lu, J., Xiang, L., Matsuura, A., Zhang, Y., Huang, Q., Qi, J., 2011. Ganodermasides C and D, two new anti-aging ergosterols from spores of the medicinal mushroom Ganoderma lucidum. Biosci. Biotechnol. Biochem. 75, 800- 803.
  • Wu, T.S., Shi, L.S., Kuo, S.C., Cherng, C.Y., Tung, S.F., Teng, C.M., 1997. Platelet aggregation inhibitor from Ganoderma lucidum. J. Chin. Chem. Soc. 44, 157-161.
  • Wu, T.S., Shi, L.S., Kuo, S.C., 2001. Cytotoxicity of Ganoderma lucidum triterpenes. J. Nat. Prod. 64, 1121-1122.
  • Wu, Q.P., Xie, Y.Z., Deng, Z., Li, X.M., Yang, W., Jiao, C.W., Fang, L., Li, S.Z., Pan, H.H., Yee, A.J., Lee, D.Y., Li, C., Zhang, Z., Guo, J., Yang, B.B., 2012. Ergosterol peroxide isolated from Ganoderma lucidum abolishes microRNA miR-378-mediated tumor cells on chemoresistance. PLoS One 7, e44579.
  • Wu, G.S., Song, Y.L., Yin, Z.Q., Guo, J.J., Wang, S.P., Zhao, W.W., Chen, X.P., Zhang, Q.W., Lu, J.-J., Wang, Y.T., 2013. Ganoderiol A-enriched extract suppresses migration and adhesion of MDA-MB-231 cells by inhibiting FAK-SRC-paxillin cascade pathway. PLoS One 8, e76620.
  • Xu, J.W., Zhao, W., Zhong, J.J., 2010. Biotechnological production and application of ganoderic acids. Appl. Microbiol. Biotechnol. 87, 457-466.
  • Yan, Y.M., Ai, J., Zhou, L.L., Chung, A.C., Li, R., Nie, J., Fang, P., Wang, X.L., Luo, J., Hu, Q., Hou, F.F., Cheng, Y.X., 2013. Lingzhiols, unprecedented rotary door-shaped meroterpenoids as potent and selective inhibitors of p-Smad3 from Ganoderma lucidum. Org. Lett. 15, 5488-5491.
  • Yang, J.J., Yu, D.Q., 1990. Synthesis of ganoderma alkaloid A and B. Yao Xue Xue Bao 25, 555-559.
  • Yang, M., Wang, X.M., Guan, S.H., Xia, J.M., Sun, J.H., Guo, H., Guo, D.A., 2007. Analysis of triterpenoids in Ganoderma lucidum using liquid chromatography coupled with electrospray ionization mass spectrometry. J. Am. Soc. Mass Spectrom. 18, 927-939.
  • Yang, S.X., Yu, Z.C., Lu, Q.Q., Shi, W.Q., Laatsch, H., Gao, J.M., 2012. Toxic lanostane triterpenes from the basidiomycete Ganoderma amboinense. Phytochem. Lett. 5, 576-580.
  • Yoon, S.Y., Eo, S.K., Kim, Y.S., Lee, C.K., Han, S.S., 1994. Antimicrobial activity of Ganoderma lucidum extract alone and in combination with some antibiotics. Arch. Pharm. Res. 17, 438-442.
  • You, B.J., Lee, M.H., Tien, N., Lee, M.S., Hsieh, H.C., Tseng, L.H., Chung, Y.L., Lee, H.Z., 2013. A novel approach to enhancing ganoderic acid production by Ganoderma lucidum using apoptosis induction. PLoS One 8, e53616.
  • Yue, Q.X., Song, X.Y., Ma, C., Feng, L.X., Guan, S.H., Wu, W.Y., Yang, M., Jiang, B.H., Liu, X., Cui, Y.J., Guo, D.A., 2010. Effects of triterpenes from Ganoderma lucidum on protein expression profile of HeLa cells. Phytomedicine 17, 606-613.
  • Yuen, J.W., Gohel, M.D., 2005. Anticancer effects of Ganoderma lucidum: a review of scientific evidence. Nutr. Cancer 53, 11-17.
  • Zhang, C.R., Yang, S.P., Yue, J.M., 2008. Sterols and triterpenoids from the spores of Ganoderma lucidum. Nat. Prod. Res. 22, 1137-1142.
  • Zhang, L., Ding, Z., Xu, P., Wang, Y., Gu, Z., Qian, Z., Shi, G., Zhang, K., 2011a. Methyl lucidenate F isolated from the ethanol-soluble-acidic components of Ganoderma lucidum is a novel tyrosinase inhibitor. Biotechnol. Bioprocess Eng. 16, 457-461.
  • Zhang, X.Q., Ip, F.C., Zhang, D.M., Chen, L.X., Zhang, W., Li, Y.L., Ip, N.Y., Ye, W.C., 2011b. Triterpenoids with neurotrophic activity from Ganoderma lucidum. Nat. Prod. Res. 25, 1607-1613.
  • Zhu, L.W., Zhong, J.J., Tang, Y.J., 2008. Significance of fungal elicitors on the production of ganoderic acid and Ganoderma polysaccharides by the submerged culture of medicinal mushroom Ganoderma lucidum. Process Biochem. 43, 1359-1370.
  • Ziegenbein, F.C., Hanssen, H.P., Konig, W.A., 2006. Secondary metabolites from Ganoderma lucidum and Spongiporus leucomallellus. Phytochemistry 67, 202- 211.